Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Mega Lifesciences Public Company Limited (MEGA)
Market Closed
10 Aug, 23:30
SET
All
(2)
TH
(2)
SET
Primary
SET
฿
38.
75
-0.5
-1.2739%
฿
29.86B
Market Cap
18.01
P/E Ratio
1.6%
Div Yield
436,345
Volume
2.72
Eps
฿
39.25
Previous Close
Watching
Watch
Add Transaction
Day Range
38.5
39.5
Year Range
27.75
40
Want to track
MEGA
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Statistics
Historical Data
Mega Lifesciences Public Company Limited (MEGA) Statistics
Valuation metrics
Market Cap
29.86B
Enterprise value
30.59B
Trailing P/E (ttm)
16.56
Forward P/E
12
PEG ratio
4.2
Price/Sales (ttm)
2.39
Price/Book (mrq)
3.26
Enterprise Value/Revenue
2.13
Enterprise Value/EBITDA
10.15
Overview
Shares outstanding
871.87M
Float
343.83M
Shares short
-
% Held by insiders
0.62%
% Held by institutions
0.11%
Average volume (10 days)
1M
Average volume (90 days)
789.67K
Price summary
52-Week low
27.75
52-Week high
40
Beta
0.27
50-Day moving average
37.22
200-Day moving average
35.89
Dividends and splits
Forward annual dividend rate
1.6
Forward annual dividend yield
0.0471%
Trailing annual dividend rate
1.6
Trailing annual dividend yield
0.0408%
5-Year annual dividend yield
3.81%
Payout ratio
0.67
Dividend Date
24 Apr 2026
Ex-Dividend Date
9 Mar 2026
Last split factor
-
Last split Date
-
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.14%
Operating margin
0.21%
Operational effectiveness
Return on assets
0.13%
Return on equity
0.2%
Income Statement
Revenue (ttm)
14.19B
Revenue per share (ttm)
16.46
Quarterly revenue growth (yoy)
0%
Gross profit (ttm)
7.43B
EBITDA
3.23B
Net income to common (ttm)
1.91B
Diluted EPS (ttm)
2.37
Quarterly earnings growth (yoy)
-0.1%
Balance Sheet
Total cash (mrq)
4.64B
Total cash per share (mrq)
5.34
Total debt (mrq)
683.54M
Total Debt/Equity (mrq)
0.06
Current ratio (mrq)
2.29%
Book value per share (mrq)
12.05
Cash Flow
Cash flow statement
2.77B
Levered free cash flow (LFCF)
2.08B